← SynDRA
BUTENAFINE
SynDRA canonical compound SYN0002981 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | SQLE |
|---|
| Mechanism of action | fungal squalene epoxidase inhibitor |
|---|
| Indication | tinea corporis | tinea cruris | tinea pedis |
|---|
| Disease area | infectious disease |
|---|
All known targets
- ACHE
- ADRA2A
- CYP2D6
- Candi ERG1
- ERG1
- Pgrmc1
- SIGMAR1
- SLC6A2
- SLC6A4
- SQLE
- fabI
Mechanisms of action (all sources)
- fungal squalene epoxidase inhibitor
- Modulator
Drug classes
- Anti-Infective Agents
- Antifungal Agents
- Benzylamine Antifungal
ATC classes
- D01A · ANTIFUNGALS FOR TOPICAL USE
Cross-references
Synonyms
- KP 363
- butenafine hydrochloride
- butenafine HCl
- Butenafina
- Butenafinum
- Mentax
- Butenafine HCL
- Butenafine [INN]
- Butenafine hydrochloride
- KP-363
- Butenafina [INN-Spanish]
- Butenafine (INN)
- Butenafinum [INN-Latin]
- Butop (TN)
- Mentax (TN)
- N-4-tert-butylbenzyl-N-methyl-1-naphthalene methylamine hydrochloride
- N-p-tert-Butylbenzyl-N-methyl-1-naphthalenemethylamine
- N-(p-tert-Butylbenzyl)-N-methyl-1-naphthalenemethylamine
- 1-(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine
- 4-tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine
- CHEBI:3238
- DTXCID5020657
- (4-tert-Butyl-benzyl)-methyl-naphthalen-1-ylmethyl-amine
- RefChem:54581
- D01AE23
- NCGC00159511-02
- CAS-101828-21-1
- MFCD00917064
- C23H27N
- Butenafine [INN:BAN]
- SR-05000001448
- UNII-91Y494NL0X
- Spectrum_001553
- BUTENAFINE [MI]
- SpecPlus_000920
- BUTENAFINE [VANDF]
- BUTENAFINE [WHO-DD]
- SCHEMBL65526
Look up BUTENAFINE in the interactive SynDRA portal →